Difference between revisions of "Apovian 2016 Am J Manag Care"

From Bioblast
Jump to: navigation, search
(Created page with "{{Publication |title=Apovian CM (2016) Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 22(7 Suppl):s176–85. |info=[https://pubmed.ncbi.nlm.nih.gov/27...")
 
Line 5: Line 5:
 
|year=2016
 
|year=2016
 
|journal=Am J Manag Care
 
|journal=Am J Manag Care
|abstract=Body mass index of 30 kg/m2 or higher is used to identify individuals with obesity. In the last 3 decades, the worldwide prevalence of obesity has increased 27.5 % for adults and 47.1 % for children. Obesity is the result of complex relationships between genetic, socioeconomic, and cultural influences. Consumption patterns, urban development, and lifestyle habits influence the prevalence of obesity. The condition may be the result of disease or pharmacologic treatment. It may also be a risk factor for the development of comorbid conditions. Persons who are obese have less school attendance, reduced earning potential, and higher healthcare costs that may result in an economic burden on society. A review of the prevalence and economic consequences of obesity is provided. Potential causes and comorbidities associated with obesity are also discussed.
+
|abstract=Body mass index of 30 kg/m<sup>2</sup> or higher is used to identify individuals with obesity. In the last 3 decades, the worldwide prevalence of obesity has increased 27.5 % for adults and 47.1 % for children. Obesity is the result of complex relationships between genetic, socioeconomic, and cultural influences. Consumption patterns, urban development, and lifestyle habits influence the prevalence of obesity. The condition may be the result of disease or pharmacologic treatment. It may also be a risk factor for the development of comorbid conditions. Persons who are obese have less school attendance, reduced earning potential, and higher healthcare costs that may result in an economic burden on society. A review of the prevalence and economic consequences of obesity is provided. Potential causes and comorbidities associated with obesity are also discussed.
 
|editor=[[Gnaiger E]],
 
|editor=[[Gnaiger E]],
 
}}
 
}}
 +
 +
::::* "People who were obese had a 55 % increased risk of depression, and people who were depressed had a 58 % increased risk of becoming obese."
 +
::::* "The paradigm shift from thinking of obesity as a character flaw to an understanding that it is a disease is monumental."
 +
 
{{Labeling
 
{{Labeling
 
|diseases=Obesity
 
|diseases=Obesity

Revision as of 21:48, 14 February 2020

Publications in the MiPMap
Apovian CM (2016) Obesity: definition, comorbidities, causes, and burden. Am J Manag Care 22(7 Suppl):s176–85.

» PMID: 27356115 Open Access

Apovian CM (2016) Am J Manag Care

Abstract: Body mass index of 30 kg/m2 or higher is used to identify individuals with obesity. In the last 3 decades, the worldwide prevalence of obesity has increased 27.5 % for adults and 47.1 % for children. Obesity is the result of complex relationships between genetic, socioeconomic, and cultural influences. Consumption patterns, urban development, and lifestyle habits influence the prevalence of obesity. The condition may be the result of disease or pharmacologic treatment. It may also be a risk factor for the development of comorbid conditions. Persons who are obese have less school attendance, reduced earning potential, and higher healthcare costs that may result in an economic burden on society. A review of the prevalence and economic consequences of obesity is provided. Potential causes and comorbidities associated with obesity are also discussed.


Bioblast editor: Gnaiger E


  • "People who were obese had a 55 % increased risk of depression, and people who were depressed had a 58 % increased risk of becoming obese."
  • "The paradigm shift from thinking of obesity as a character flaw to an understanding that it is a disease is monumental."


Labels: Pathology: Obesity 

Organism: Human 

Preparation: Intact organism 




BMI